prenatal genetics
DESCRIPTION
owen phillips prenatal genetics memphis obgyn pregnancyTRANSCRIPT
Prenatal Genetics
Owen Phillips, MD
Reproductive Genetics
Objectives:Predicting fetal health
as it pertains to genetic issues
1.Learn counseling issues concerning family history
2. Understand forms and indications for prenatal testing and screening
3% of all babies- major congenital anomaly.
Causes of birth defects:
1. Genetic factors– 14%
2. Environmental factors- 7%
3. Multifactorial (combination of 1 and 2)- 25%
4. Unknown etiology- 54%
Patient (Reproductive) History
• Previously affected offspring
• Stillbirths
• Spontaneous abortions
• Infertility and ART
• Teratogenic exposure
• Pedigree
Risk Factors for Offspring with a Chromosome Abnormality
• Maternal age (>35)
• Previous affected (1-2%)
• Maternal serum screening
• Ultrasound findings– Specific risk depends on abnormality
• Carrier of chromosome rearrangements– Most ascertained because of spontaneous
losses
Counseling
• Purposes, potential results and the implications of results
• Routine genetic screening is routinely offered, not routinely performed
• Tests should not be performed without the knowledge of the patient
Amniocentesis
• > or = 14 weeks gestation
• Loss rate 1/1000 above baseline risk
• Infection/injury to fetus- <1/1000
• Accuracy > 99.5 % detection rate chromosome abnormalities
Amniocentesis
First-trimester Prenatal Diagnosis
1. Alleviate stressful aspects of prenatal testing
2. Provides privacy concerning pregnancy management decisions
3. Safety of first- versus second-trimester termination
Testing must prove to be safe and accurate as traditional amniocentesis.
CVSTranscervical
CVSTransabdominal
Summary of CVS
• In experienced hands, loss rate from CVS comparable to Amnio
• TC and TA CVS risks comparable
• Infection rate (1/1000) similar amniocentesis
• As accurate as Amniocentesis
Screening for chromosome abnormalities
• Second trimester- a blood test– hCG, estriol, AFP– 60% Down syndrome
• First trimester- U/S and blood test– Certified sonosgrapher– PAPP-A, hCG
Autosomal Dominant Disorders
• Adult polycystic kidney disease
• Achondroplasia• Ehlers-Danlos
sydrome, type 1• Familial
hypercholesterolemia• Familial colonic
polyposis
• Huntington disease• Marfan syndrome• Myotonic dystrophy• Neurofibromatosis• Noonan syndrome
Autosomal Recessive Disorders
• Alpha-1-antitrypsin deficiency
• Congenital adrenal hyperplasia (21-hydroxylase deficiency)
• Cystic fibrosis• Homocystinuria• Meckel-Gruber syndrome• Thalassemia (alpha and
beta)
• Phenylketonuria
• Refsum disease
• Sickle cell anemia• Tay-Sachs disease• Wilson disease• Hurler syndrome
X-Linked Recessive Diseases
Duchenne muscular distrophyHemophilia BEhlers-Danlos syndrome, type V Hunter syndrome (Mucopolysaccharidosis II) Glucose-6-phosphate deficiency Fragile XHemophilia ALesch-Nyham syndrome
Family history of single gene defects
• Need information prior to pregnancy- specific disease
• Takes months + to define mutations
• Early prenatal diagnosis- may take weeks to make a diagnosis
Physician’s Concerns
• Family History of MR
• Ethnic background
• Ultrasound Findings
• Results of screening tests
• Teratogen exposure
Ethnic background
• Jewish
• Greek / Mediterranean
• African-American
• Asian
Ashkenazic Jewish Heritage
“Jewish panel” for carrier detection– Tay-Sachs– Canavan– CF– +/- non-classical Gaucher– Bloom syndrome– Nieman-Pick– Familial Dysautonomia
Other Ethnicities
• Mediterranean– Beta Thalassemia
• African American– Beta Thalassemia– Sickle Cell
• Asian-American– Beta Thalassemia– Alpha Thalassemia
The Future is Here
• All patients will be candidates for having information about their pregnancies
• Screening all low risk pregnancies
• Offered by various companies
• Impact? Candidates?
Microarray testing for 63 genetic disorders
using 1755 unique probes
Drawbacks
• Cost
• ‘Fishing’- parents may carry benign mutation
• Counseling to explain each disease to give a couple enough information
• Maybe in a certain setting with informed consent on the front end
Ultrasound to diagnose genetic disorders
• Specific findings associated with specific disease
Ultrasound is a genetic screening tool
• Fetal survey– 16-18 weeks
Drugs and Chemicals
Pregnant women take an average of 4 drugs during pregnancy
40% of these drugs are taken during the critical period associated with teratogenicity
Teratogenic agents
1) Drugs and chemicals
2) Infectious agents
3) Radiation
4) Other